These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19169162)

  • 1. Attitudes of obstetrician-gynecologists toward the evidence from the Women's Health Initiative hormone therapy trials remain generally skeptical.
    Power ML; Anderson BL; Schulkin J
    Menopause; 2009; 16(3):500-8. PubMed ID: 19169162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy.
    Power ML; Zinberg S; Schulkin J
    Menopause; 2006; 13(3):434-41. PubMed ID: 16735940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving practice patterns and attitudes toward hormone therapy of obstetrician-gynecologists.
    Power ML; Schulkin J; Rossouw JE
    Menopause; 2007; 14(1):20-8. PubMed ID: 17019376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with obstetrician-gynecologists' response to the Women's Health Initiative trial of combined hormone therapy.
    Power ML; Baron J; Schulkin J
    Med Decis Making; 2008; 28(3):411-8. PubMed ID: 18480040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
    Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
    Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the WHI study on the attitude of Israeli gynecologists to hormonal therapy during menopause.
    Kaplan B; Yogev Y; Orvieto R; Hirsch M; Fisher M; Rabinerson D
    Clin Exp Obstet Gynecol; 2004; 31(4):267-8. PubMed ID: 15672962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported changes in providers' hormone therapy prescribing and counseling practices after the Women's Health Initiative.
    Lakey SL; Reed SD; LaCroix AZ; Grothaus L; Newton KM
    J Womens Health (Larchmt); 2010 Dec; 19(12):2175-81. PubMed ID: 21062201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge and personal use of menopausal hormone therapy among Chinese obstetrician-gynecologists: results of a survey.
    Wang Y; Yang X; Li X; He X; Zhao Y
    Menopause; 2014 Nov; 21(11):1190-6. PubMed ID: 24736196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of hormone therapy by female gynecologists and female partners of male gynecologists in Germany 8 years after the Women's Health Initiative study: results of a survey.
    Buhling KJ; von Studnitz FS; Jantke A; Eulenburg C; Mueck AO
    Menopause; 2012 Oct; 19(10):1088-91. PubMed ID: 22692331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstetrician-gynecologists and contraception: practice and opinions about the use of IUDs in nulliparous women, adolescents and other patient populations.
    Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
    Contraception; 2014 Jun; 89(6):572-7. PubMed ID: 24679477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstetrician-gynecologists' approach to well-woman care.
    Morgan MA; Lawrence H; Schulkin J
    Obstet Gynecol; 2010 Sep; 116(3):715-722. PubMed ID: 20733457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstetrician-gynecologists' opinions on elective bilateral oophorectomy at the time of hysterectomy in the United States: a nationwide survey.
    Harmanli O; Shinnick J; Jones K; St Marie P
    Menopause; 2014 Apr; 21(4):355-60. PubMed ID: 23942250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes.
    Bush TM; Bonomi AE; Nekhlyudov L; Ludman EJ; Reed SD; Connelly MT; Grothaus LC; LaCroix AZ; Newton KM
    J Gen Intern Med; 2007 Sep; 22(9):1311-6. PubMed ID: 17634782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The attitude of gynecologists in São Paulo, Brazil 3 years after the Women's Health Initiative study.
    Lazar F; Costa-Paiva L; Morais SS; Pedro AO; Pinto-Neto AM
    Maturitas; 2007 Feb; 56(2):129-41. PubMed ID: 16901660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetrician-gynecologists' patients' knowledge of and attitudes toward hormone therapy: a survey.
    Power ML; Schulkin J
    J Reprod Med; 2006 Jul; 51(7):525-32. PubMed ID: 16913542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy.
    Taylor HS; Kagan R; Altomare CJ; Cort S; Bushmakin AG; Abraham L
    Menopause; 2017 Jan; 24(1):27-34. PubMed ID: 27575548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What factors influence obstetrician-gynecologists to follow recommended HIV screening and testing guidelines?
    Anderson BL; Carlson R; Anderson J; Hawks D; Schulkin J
    J Womens Health (Larchmt); 2012 Jul; 21(7):762-8. PubMed ID: 22506919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
    Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education.
    Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J
    Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.